Skip to main content
. 2020 Jul 20;12(7):1968. doi: 10.3390/cancers12071968
AE adverse event
AHR adjusted hazard ratio
AOR adjusted odds ratio
CI confidence interval
DCR disease control rate
ECOG Eastern Cooperative Oncology Group
HCC hepatocellular carcinoma
HR hazard ratio
IQR interquartile range
mRECIST modified Response Evaluation Criteria in Solid Tumors
OS overall survival
ORR objective response rate
PFS progression-free survival
RECIST Response Evaluation Criteria in Solid Tumors
TTP time to progression